ReviewHeart failure clinics2014
Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure.
Review in Heart failure clinics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 71 citations in OpenAlex.
- Heart failure in autoimmune rheumatic diseases.Rheumatology international · 2026Review
- Heart Failure Risk in Patients With Systemic Autoimmune Inflammatory Diseases.Journal of the American Heart Association · 2026Article
- Prognostic impact of rheumatic diseases in patients with heart failure with mildly reduced ejection fraction.Clinical research in cardiology : official journal of the German Cardiac Society · 2025Article
- Current understanding and management of cardiovascular involvement in rheumatic immune-mediated inflammatory diseases.Nature reviews. Rheumatology · 2024Review
- Cardiovascular manifestations and comorbidities in rheumatic diseases: perspectives on timely diagnosis, prevention, and treatment.Clinical rheumatology · 2023Article
- Sex Differences in Heart Failure: What Do We Know?Journal of cardiovascular development and disease · 2023Review
- Is the Calcium Score Useful for Rheumatoid Arthritis Patients at Low or Intermediate Cardiovascular Risk?Journal of clinical medicine · 2022Article
- Cardiovascular Risk in Myositis Patients Compared to the General Population: Preliminary Data From a Single-Center Cross-Sectional Study.Frontiers in medicine · 2022Article
- Phenotypic Presentations of Heart Failure Among Patients With Chronic Inflammatory Diseases.Frontiers in cardiovascular medicine · 2022Article
- Ischemic Heart Disease and Rheumatoid Arthritis-Two Conditions, the Same Background.Life (Basel, Switzerland) · 2021Review
- Annexin A1 attenuates cardiac diastolic dysfunction in mice with inflammatory arthritis.Proceedings of the National Academy of Sciences of the United States of America · 2021Article
- Comorbidities Before and After the Diagnosis of Rheumatoid Arthritis: A Matched Longitudinal Study.ACR open rheumatology · 2020Article
- Echocardiography in Autoimmune Rheumatic Diseases for Diagnosis and Prognosis of Cardiovascular Complications.Medicina (Kaunas, Lithuania) · 2020Review
- Refocusing on the Primary Prevention of Heart Failure.Current treatment options in cardiovascular medicine · 2020Article
- Differential Associations of Chronic Inflammatory Diseases With Incident Heart Failure.JACC. Heart failure · 2020Article
- Association of Lymphopenia With Risk of Mortality Among Adults in the US General Population.JAMA network open · 2019Article
- Comorbidities As Risk Factors for Rheumatoid Arthritis and Their Accrual After Diagnosis.Mayo Clinic proceedings · 2019Article
- Myocardial Microvascular Dysfunction in Rheumatoid ArthritisCirculation. Cardiovascular imaging · 2019Article
- Inflammation and Coronary Microvascular Dysfunction in Autoimmune Rheumatic Diseases.International journal of molecular sciences · 2019Review
- Mesenchymal TNFR2 promotes the development of polyarthritis and comorbid heart valve stenosis.JCI insight · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
Rheumatic diseases are associated with an increased risk of cardiovascular (CV) mortality attributed to a higher incidence of heart failure (HF) and ischemic heart disease. Although traditional CV risk factors contribute to the increased incidence seen in this population, by themselves they do not account for the increased risk; in fact, obesity and hyperlipidemia may play a paradoxic role. Immune-mediated mechanisms and chronic inflammation likely play a role in the pathogenesis of CV disease in patients with rheumatic diseases. The usual clinical features of ischemic heart disease and HF are less likely to be seen in this patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.